WW International, Inc. (WW)
NASDAQ: WW · Real-Time Price · USD
9.80
-0.71 (-6.76%)
At close: Apr 28, 2026, 4:00 PM EDT
9.96
+0.16 (1.63%)
After-hours: Apr 28, 2026, 7:58 PM EDT

Company Description

WW International, Inc. provides weight management products and services in the United States, Germany, Canada, and internationally.

It offers various nutritional, activity, behavioral, and lifestyle tools and approaches for individual weight goals, as well as for people taking GLP-1 medications or living with diabetes, as well as offers guidance and medication access for women reaching perimenopause and menopause.

The company also provides Core, a digital subscription product for weight loss and weight management; Core+ tier, a subscription for unlimited access to workshops; and Med+ subscription tier provides unlimited access to a clinician who can prescribe medications when clinically appropriate, including oral and injectable GLP 1s and hormone replacement therapy.

In addition, it licenses its trademarks and other intellectual property in food, beverages, and other weight management-relevant consumer products and services, as well as provides publishing services.

The company was formerly known as Weight Watchers International, Inc. and changed its name to WW International, Inc. in September 2019.

WW International, Inc. was founded in 1963 and is headquartered in New York, New York.

WW International, Inc.
WW International logo
Country United States
Founded 1963
Industry Medical Care Facilities
Sector Healthcare
Employees 3,500
CEO Jonathan Volkmann

Contact Details

Address:
18 West 18th Street, 7th Floor
New York, New York 10011
United States
Phone 212 589 2700
Website corporate.ww.com

Stock Details

Ticker Symbol WW
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000105319
CUSIP Number 98262P101
ISIN Number US98262P2002
Employer ID 11-6040273
SIC Code 7200

Key Executives

Name Position
Julie J. Rice Chief Experience Officer
Felicia DellaFortuna Chief Financial Officer and Member of Interim Office of the Chief Executive
Jonathan Volkmann Chief Operating Officer and Interim Principal Executive Officer
Nicole Haag Corporate Controller and Principal Accounting Officer
Helene Causse Chief Technology Officer
David Helderman Director of Investor Relations
Debra Cotter Chief Legal Officer and Secretary
Nina George Chief Marketing and Consumer Strategy Officer
Tony Yen Head of Taiwan
Scott Honken PharmD Chief Commercial Officer

Latest SEC Filings

Date Type Title
Apr 27, 2026 8-K Current Report
Apr 20, 2026 8-K Current Report
Apr 17, 2026 8-K Current Report
Apr 9, 2026 8-K/A [Amend] Current report
Apr 7, 2026 8-K Current Report
Apr 3, 2026 8-K Current Report
Mar 26, 2026 SCHEDULE 13G/A Filing
Mar 19, 2026 SCHEDULE 13G Filing
Mar 16, 2026 10-K Annual Report
Mar 16, 2026 8-K Current Report